Specialty drugs take up a bigger part of pharmacy spending in the US. In recent years, they made up about 40% of pharmacy benefit costs. This amount might grow to nearly 48%. Prices for these drugs went up about 9.6% each year between 2014 and 2015. The prices keep rising, especially for cancer treatments.
The increase is partly because many new specialty drugs are being developed. In 2017, 60% of new drugs approved were specialty medicines. Cancer and gene therapies are the main areas of growth. Using complex treatments like cell and gene therapies creates big cost issues for health systems. Around 73% of health plans expect these drugs will cause big cost problems in two to three years.
Along with higher costs, there are other problems. Pharmacies deal with sicker patients and harder treatments. They also face staff shortages and problems with drug supplies. These issues make it harder to provide good care on time.
Group Purchasing Organizations (GPOs) help control specialty drug costs by negotiating lower prices. Companies like AmerisourceBergen work with health systems to create purchasing deals that fit each system’s needs. These deals help save money.
Improving following of drug lists is also important. Systems that stick to their formularies over 95% of the time save 5 to 10% on drug costs. This is especially true in critical care areas. Sticking to these guidelines helps systems get discounts without hurting patient care.
Health systems are building or growing specialty pharmacy and infusion services. These help keep patient care connected and improve satisfaction and health results. McKesson Corporation offers customizable care models. Patients get specialty drugs and infusions within the health system. This stops care from being split up and helps patients stick to their medications.
However, setting up these programs is complex. They need coordination of patient therapies, help with payments, and clinical teaching. This requires good management and trained staff.
Dose optimization can reduce drug quantities without lowering how well they work. This lowers costs and makes it easier for patients to take their medicines. At Diplomat Specialty Pharmacy, a pilot study found 58 dose optimization chances that saved about $135,000.
Still, dose optimization faces problems like delays from extra approvals, insurance issues, and different goals of payers, pharmacies, and patients. Fixing these problems needs everyone to work better together and communicate clearly.
Loss and poor control of inventory raise costs in specialty pharmacies. Tools like Nucleus Inventory Management and Cubixx Solutions help track medicines in real time. Technologies such as RFID tagging improve stock forecasts and stop having too much or too little. These systems help keep important drugs ready while controlling costs.
Hospitals and clinics use many ways to fix staffing shortages in pharmacy technician roles. These include flexible schedules, higher pay, remote work for some tasks, and online training. Pharmacists and leaders also ask pharmacy schools to offer more career options beyond regular jobs. New paths include pharmacy benefits management, infusion centers, and health IT.
One of the best ways to improve drug cost management is by using artificial intelligence (AI) and automation. These tools can help many parts of specialty pharmacy and health system work:
AI can handle prior authorizations by quickly checking patient eligibility, drug lists, and medical history. This lowers delays caused by manual work. Automated claims also speed up payments and cut admin work.
AI looks at past drug use, patient info, and treatment results to predict future needs. This helps plan inventory and stops too much expensive drug stock. AI also finds early signs of patients not following therapy, so staff can fix problems quickly.
AI platforms gather data from pharmacy, clinical, and financial systems. This gives a full view of specialty drug cost and results. It helps teams like supply chain managers, pharmacists, and finance staff make better choices for buying and using drugs.
AI chatbots and virtual assistants help patients with drug questions, refill reminders, and education about side effects. This helps patients take their meds as they should. Better adherence means less waste and lower costs.
Using AI with RFID and smart monitors, health systems track drug amounts and locations all the time. Alerts warn staff if stock is low or drugs are near expiration. Automated ordering based on predictions keeps important medicines available without extra stock.
IT managers in medical practices can use AI and automation to reduce manual work, improve data accuracy, and better control costly drug inventories. This helps with both money and patient care.
Health systems work more with drug makers, distributors, payers, and consultants to handle specialty drug costs. These partnerships include sharing data, investing together, and creating new care and cost strategies.
Still, many health systems stick mainly to traditional partnerships. They do not always look at things like investing with payers, private equity, or startups focused on specialty drugs. Expanding partnerships can help share financial risks, make supply chains stronger, and speed up new care methods.
Research shows that ambulatory specialty pharmacies, home infusion therapies, retail pharmacy services, and mail-order models are not fully developed in many health systems. Growing these areas can make things easier for patients, improve medicine use, bring more income, and let systems better control drug use.
About 85% of pharmacy leaders in health systems plan to grow ambulatory and specialty networks. Around 70% focus on home infusion services. Growing retail and mail-order pharmacies also helps manage specialty drugs well. This focus helps patients get care where and when they want it, creating less care split-up and better results.
Specialty drug costs are rising in US health systems. This is because of new costly therapies and complex treatments. Medical practice leaders, owners, and IT staff need to use many methods. These include smart drug buying, program building, dose optimization, managing inventory, fixing staffing, and using new technology like AI.
Improving adherence to drug lists, starting specialty pharmacy and infusion services, using data well, and making partnerships with drug makers and payers can keep costs manageable. At the same time, patients keep access to important specialty meds.
Automation and AI help reduce paperwork, make decisions better, and improve control over drug costs. Using these tools can help health systems handle rising specialty drug expenses while keeping care quality and patient health strong.
Health system-owned clinics, like those under the Integrated Nephrology Network (INN), provide essential contracts and resources aimed at improving operational efficiencies and controlling costs for nephrology practices and dialysis providers.
INN offers nephrology practices critical contracts, clinical education, and business resources to help them adapt to the changing landscape of chronic kidney disease while enhancing patient care.
Group Purchasing Organizations (GPOs) like INN help nephrology practices access specialized products at contracted terms, improving profitability and patient access, while providing business-enhancing technology and services.
Tailored purchasing strategies designed by organizations like AmerisourceBergen focus on specialty drug purchasing, maximizing financial performance, and optimizing patient access to oncology and specialty products.
Solutions like Nucleus Inventory Management prevent inventory losses and control costs through smart stations and integrated portals, enabling nephrology practices to maintain critical therapy supplies.
Operational efficiencies are vital in dialysis centers as they directly impact cost management, patient care quality, and overall financial viability in a competitive healthcare environment.
Specialty pharmacy services ensure that patients have quick access to necessary specialty medications, improving initiation of therapy and contributing to better clinical outcomes.
Cubixx Solutions offers RFID technology for 24/7 inventory monitoring, enhancing product usage forecasting and optimizing future orders in healthcare settings.
Health systems increasingly face challenges with rising oncology and specialty drug expenditures impacting profitability, necessitating optimized purchasing and cost management strategies.
Integrating advanced technology in nephrology practices helps streamline operations, improve patient access to treatments, and enhance overall financial performance by leveraging real-time data and analytics.